Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Engineering Poly(lactic Acid)-Based Scaffolds for Abundant, Sustained, and Prolonged Lactate Release

  • Haro Gutiérrez, Pilar A.
  • Colombi, Samuele
  • Casanovas Salas, Jordi
  • Resina, Leonor
  • Sans, Jordi
  • Engel, Elisabeth
  • Enshaei, Hamidreza
  • García-Torres, José
  • Pérez-Madrigal, Maria M.
  • Alemán, Carlos
Recent studies have revealed that cardiac tissue regeneration is promoted by administering an initial dose of exogenous lactate and locally maintaining an abundant concentration of this compound for a prolonged period (i.e., around 10–14 days) through sustained release. The aim of this study is to develop a scaffold based on poly(lactic acid) (PLA) for achieving a sustained daily release of lactate from the first day to the end of the recommended period. First, a five-layered electroresponsive scaffold has been engineered using three PLA layers (first, third, and fifth), each composed of electrospun microfibers (MFs), separated by spin coated lactate (second) and poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) (fourth) intermediate layers. The hydrophobicity of the outer PLA layers (first and fifth) has been used to maintain the release of lactate from the intermediate second layer over 3 days, while the conducting fourth PEDOT:PSS layer has ensured a complete lactate release by electrostimulation. After that, in a second step, the same scaffold has been re-engineered to maintain the sustained release not only for a short period (3 days) but also for a prolonged period (>10 days). For this purpose, the PLA MFs of the intermediate third layer have been substituted by plasma-treated proteinase K-containing PLA MFs, obtained by electrospinning a PLA:enzyme mixture. The activity of the enzyme, which decomposes the ester bonds of PLA, combined with the effect of the plasma on the PLA structure, results in a prolonged sustained release that, in addition, can be modulated., This publication is part of the I+D+i projects PID2021-125767OB-I00, PLEC2022-009279, PID2021-128412OB-I00, PDC2022-133755-I00, and CEX2023-001300-M funded by MCIN/AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe” and European Union Next Generation EU (REGOMUC and BIOMATCH projects). The authors thank the Agencia ̀ de Gestió d’Ajuts Universitaris i de Recerca (2021 SGR 00387) for financial support. P.A.H.-G. thanks CONACYT (México) for the financial support through a postgraduate scholarship (836603 CVU 347614). S.C. thanks the Agencia ̀ de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; Generalitat de Catalunya) for a FI Fellowship. E.E. received funding from the CERCA program by the Generalitat de Catalunya and the ″Centro de Excelencia Severo Ochoa″ (grant CEX2023-001282-S, funded by MICIU/AEI/10.13039/ 501100011033). M.M.P.-M. thanks the Ministerio de Ciencia, Innovación y Universidades for the Junior Beatriz Galindo Award (BG20/00216). J.G.-T. acknowledges the Serra Hunter program of the Generalitat de Catalunya. Support for the research of E.E. and C.A. was also received through the prize “ICREA Academia” for excellence in research funded by the Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Conductive Bacterial Nanocellulose-Polypyrrole Patches Promote Cardiomyocyte Differentiation

  • Srinivasan, Sumithra Y.
  • Cler, Marina
  • Zapata Arteaga, Osnat
  • Dörling, Bernhard
  • Campoy Quiles, Mariano
  • Martínez Fernández, Elena
  • Engel, Elisabeth
  • Pérez Amodio, Soledad
  • Laromaine, Anna
The low endogenous regenerative capacity of the heart, added to the prevalence of cardiovascular diseases, triggered the advent of cardiac tissue engineering in the last decades. The myocardial niche plays a critical role in directing the function and fate of cardiomyocytes; therefore, engineering a biomimetic scaffold holds excellent promise. We produced an electroconductive cardiac patch of bacterial nanocellulose (BC) with polypyrrole nanoparticles (Ppy NPs) to mimic the natural myocardial microenvironment. BC offers a 3D interconnected fiber structure with high flexibility, which is ideal for hosting Ppy nanoparticles. BC-Ppy composites were produced by decorating the network of BC fibers (65 ± 12 nm) with conductive Ppy nanoparticles (83 ± 8 nm). Ppy NPs effectively augment the conductivity, surface roughness, and thickness of BC composites despite reducing scaffolds' transparency. BC-Ppy composites were flexible (up to 10 mM Ppy), maintained their intricate 3D extracellular matrix-like mesh structure in all Ppy concentrations tested, and displayed electrical conductivities in the range of native cardiac tissue. Furthermore, these materials exhibit tensile strength, surface roughness, and wettability values appropriate for their final use as cardiac patches. In vitro experiments with cardiac fibroblasts and H9c2 cells confirmed the exceptional biocompatibility of BC-Ppy composites. BC-Ppy scaffolds improved cell viability and attachment, promoting a desirable cardiomyoblast morphology. Biochemical analyses revealed that H9c2 cells showed different cardiomyocyte phenotypes and distinct levels of maturity depending on the amount of Ppy in the substrate used. Specifically, the employment of BC-Ppy composites drives partial H9c2 differentiation toward a cardiomyocyte-like phenotype. The scaffolds increase the expression of functional cardiac markers in H9c2 cells, indicative of a higher differentiation efficiency, which is not observed with plain BC. Our results highlight the remarkable potential use of BC-Ppy scaffolds as a cardiac patch in tissue regenerative therapies., This work was supported by the Spanish Ministry of Science and Innovation (MICINN) through the National Research Agency (AEI) and European Regional Development Funds (ERDF/FEDER), project BIOCARDIO ref RTI2018-096320–B-C21, project BIOSOFT-REGE ref PID2021-122645OB-I00, the CERCA Program/Generalitat de Catalunya, the ‘Severo Ochoa’ Programme for Center of Excellence in R&D (CEX2019-000917), the Programme/Generalitat de Catalunya (2017-SGR-359), the Severo Ochoa Programme of the Spanish Ministry of Science and Innovation (MICINN─Grant SEV-2014–0425, 2015–2019 and CEX2018–000,789-S, 2019–2023), and the projects FIP-PALOMA, FIP-BEAT, and the PDC2022-133755-I00/AEI/10.13039/501100011033 European Union NextGeneration EU/PRTR. This research was also supported by the European Union’s Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, Grant Agreement No. 754397). This project also received the support of a La Caixa INPhINIT Fellowship (ID 100010434) with project code LCF/BQ/DR19/11740025. S.Y.S. is enrolled in the Materials Science Ph.D. program of the UAB. S.Y.S. and A.L. participate in the Spanish National Research Council (CSIC) interdisciplinary platform for sustainable plastics towards a circular economy (SusPlast), in the Aerogels COST ACTION (CA 18125), and in CSIC-Conexión Nanomedicine, EPNOE network, and Red Nanocare 2.0. The authors acknowledge the use of Biorender.com., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Advances in Conductive Nanomaterials for Cardiac Arrhythmia and Future Directions in Bioevaluation Strategies

  • Srinivasan, Sumithra Y.
  • Laromaine, Anna
Cardiac arrhythmia (CA), characterized by irregular heart rhythms, affects nearly 90% of individuals with cardiovascular diseases. Commonly triggered by myocardial infarction (MI) or ion channel dysfunctions, CA is traditionally treated using pacemakers, cardioversion, ablation, and anti-arrhythmic drugs. Recently, emerging strategies like cardiac patches and injectable formulations with conductive nanomaterials (CNMs) have shown promise in restoring cardiac rhythm post-MI. This review explores CNMs-such as gold nanoparticles, carbon nanotubes, and conjugated polymers-that mimic the electrical and mechanical properties of native cardiac tissue. While in vitro studies show encouraging results, translating CNMs to clinical settings faces challenges. Few studies have assessed their safety and efficacy in rodent models, and none in larger animals. This gap stems from the complexity and ethical hurdles of large animal research. To address this, the review advocates using small animal models like zebrafish, Drosophila melanogaster, and Caenorhabditis elegans. These models offer insights into pharmacokinetics, pharmacodynamics, genetic effects, and cardiac parameters such as ejection fraction and cardiac output-data often unattainable in vitro. Such platforms can better evaluate CNMs' safety and efficacy than 2D/3D cultures, accelerating progress toward clinical application., This work was supported by the Spanish Ministry of Science and Innovation (MICINN) through the National Research Agency (AEI) and European Regional Development Funds (ERDF/FEDER), project BIOSOFT-REGE ref PID2021-122645OB-I00, BACTIVE ref PID2024-1576370B-I00, BIOCCHIP ref PDC2023-145826-I00, the Program/Generalitat de Catalunya (2021SGR00446 project), the Severo Ochoa Program of the Spanish Ministry of Science and Innovation (MICINN_Grant CEX2018−000,789-S, CEX2023-001263-S), and the projects FIP-BEAT, and the PDC2022-133755-I00/AEI/10.13039/501100011033 European Union NextGeneration EU/PRTR. This research was also supported by the European Union's Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, Grant Agreement No. 754397), European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). Authors participate in the Spanish National Research Council (CSIC) interdisciplinary platform for sustainable plastics toward a circular economy (SusPlast), and in CSIC-Conexion Nanomedicina del CSIC, EPNOE network, and Red Nanocare 2.0, Grant RED2022-134560-T funded by MCIN/AEI/10.13039/501100011033. The authors acknowledge the use of Biorender.com., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Engineering Poly(lactic Acid)-Based Scaffolds for Abundant, Sustained, and Prolonged Lactate Release

  • Haro Gutiérrez, Pilar A.
  • Colombi, Samuele
  • Casanovas Salas, Jordi
  • Resina, Leonor
  • Sans, Jordi
  • Engel, Elisabeth
  • Enshaei, Hamidreza
  • García-Torres, José
  • Pérez-Madrigal, Maria M.
  • Alemán, Carlos
Recent studies have revealed that cardiac tissue regeneration is promoted by administering an initial dose of exogenous lactate and locally maintaining an abundant concentration of this compound for a prolonged period (i.e., around 10–14 days) through sustained release. The aim of this study is to develop a scaffold based on poly(lactic acid) (PLA) for achieving a sustained daily release of lactate from the first day to the end of the recommended period. First, a five-layered electroresponsive scaffold has been engineered using three PLA layers (first, third, and fifth), each composed of electrospun microfibers (MFs), separated by spin coated lactate (second) and poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) (fourth) intermediate layers. The hydrophobicity of the outer PLA layers (first and fifth) has been used to maintain the release of lactate from the intermediate second layer over 3 days, while the conducting fourth PEDOT:PSS layer has ensured a complete lactate release by electrostimulation. After that, in a second step, the same scaffold has been re-engineered to maintain the sustained release not only for a short period (3 days) but also for a prolonged period (>10 days). For this purpose, the PLA MFs of the intermediate third layer have been substituted by plasma-treated proteinase K-containing PLA MFs, obtained by electrospinning a PLA:enzyme mixture. The activity of the enzyme, which decomposes the ester bonds of PLA, combined with the effect of the plasma on the PLA structure, results in a prolonged sustained release that, in addition, can be modulated., This publication is part of the I+D+i projects PID2021-125767OB-I00, PLEC2022-009279, PID2021-128412OB-I00, PDC2022-133755-I00, and CEX2023-001300-M funded by MCIN/AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe” and European Union Next Generation EU (REGOMUC and BIOMATCH projects). The authors thank the Agencia ̀ de Gestió d’Ajuts Universitaris i de Recerca (2021 SGR 00387) for financial support. P.A.H.-G. thanks CONACYT (México) for the financial support through a postgraduate scholarship (836603 CVU 347614). S.C. thanks the Agencia ̀ de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; Generalitat de Catalunya) for a FI Fellowship. E.E. received funding from the CERCA program by the Generalitat de Catalunya and the ″Centro de Excelencia Severo Ochoa″ (grant CEX2023-001282-S, funded by MICIU/AEI/10.13039/ 501100011033). M.M.P.-M. thanks the Ministerio de Ciencia, Innovación y Universidades for the Junior Beatriz Galindo Award (BG20/00216). J.G.-T. acknowledges the Serra Hunter program of the Generalitat de Catalunya. Support for the research of E.E. and C.A. was also received through the prize “ICREA Academia” for excellence in research funded by the Generalitat de Catalunya.